335 related articles for article (PubMed ID: 19376755)
41. [Abnormal haemoglobins in the newborn human population of Costa Rica].
Abarca G; Navarrete M; Trejos R; de Céspedes C; Saborío M
Rev Biol Trop; 2008 Sep; 56(3):995-1001. PubMed ID: 19419022
[TBL] [Abstract][Full Text] [Related]
42. An evaluation of the Sebia capillarys Neonat Haemoglobin FAST™ system for routine newborn screening for sickle cell disease.
Murray C; Hall SK; Griffiths P
Int J Lab Hematol; 2011 Oct; 33(5):533-9. PubMed ID: 21535479
[TBL] [Abstract][Full Text] [Related]
43. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
[TBL] [Abstract][Full Text] [Related]
44. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
[TBL] [Abstract][Full Text] [Related]
45. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
[TBL] [Abstract][Full Text] [Related]
46. Student screening for inherited blood disorders in Bahrain.
Al-Arrayed S; Hafadh N; Amin S; Al-Mukhareq H; Sanad H
East Mediterr Health J; 2003 May; 9(3):344-52. PubMed ID: 15751927
[TBL] [Abstract][Full Text] [Related]
47. [Sickle cell disease neonatal screening. First evaluation].
Mbodj M; Ndoye O; Diarra M; Mbaye BN; Sow Toure H; Diouf L; Gassama Seck S; Dhondt JL; Farriaux JP
Dakar Med; 2003; 48(3):202-5. PubMed ID: 15776632
[TBL] [Abstract][Full Text] [Related]
48. [Sickle cell disease in heel injection screening. II].
Vansenne F; de Borgie CA; Bouva MJ; Legdeur MA; van Zwieten R; Petrij F; Peters M
Ned Tijdschr Geneeskd; 2009 May; 153(18):858-61. PubMed ID: 19475864
[No Abstract] [Full Text] [Related]
49. Sickle cell disease.
Kato GJ; Piel FB; Reid CD; Gaston MH; Ohene-Frempong K; Krishnamurti L; Smith WR; Panepinto JA; Weatherall DJ; Costa FF; Vichinsky EP
Nat Rev Dis Primers; 2018 Mar; 4():18010. PubMed ID: 29542687
[TBL] [Abstract][Full Text] [Related]
50. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
[TBL] [Abstract][Full Text] [Related]
51. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola.
McGann PT; Ferris MG; Ramamurthy U; Santos B; de Oliveira V; Bernardino L; Ware RE
Am J Hematol; 2013 Dec; 88(12):984-9. PubMed ID: 24038490
[TBL] [Abstract][Full Text] [Related]
52. [Neonatal screening for hemoglobinopathies in the Brussels region].
Tshilolo L; Gulbis B; Barlow P; Damis E; Denis-Song R; Ferster A; Haumont D; Vanderpas JB; Pardou A; Schwers J; Vokaer A; Vertongen F
Rev Med Brux; 1997 Apr; 18(2):70-3. PubMed ID: 9221465
[TBL] [Abstract][Full Text] [Related]
53. Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.
Lobitz S; Frömmel C; Brose A; Klein J; Blankenstein O
Eur J Hum Genet; 2014 Aug; 22(8):1051-3. PubMed ID: 24398797
[TBL] [Abstract][Full Text] [Related]
54. Update: new guidelines for the treatment of infants with sickle cell disease. Agency for Health Care Policy and Research.
Selekman J
Pediatr Nurs; 1993; 19(6):600-5. PubMed ID: 8278235
[TBL] [Abstract][Full Text] [Related]
55. Neonatal screening for sickle cell disease in Central Africa: a study of 1825 newborns with a new enzyme-linked immunosorbent assay test.
Mutesa L; Boemer F; Ngendahayo L; Rulisa S; Rusingiza EK; Cwinya-Ay N; Mazina D; Kariyo PC; Bours V; Schoos R
J Med Screen; 2007; 14(3):113-6. PubMed ID: 17925082
[TBL] [Abstract][Full Text] [Related]
56. [Sickle cell disease: exotic disease or a Belgian public health problem?].
Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
[TBL] [Abstract][Full Text] [Related]
57. [Generalized neonatal screening based on laboratory tests].
Ardaillou R; Le Gall JY
Bull Acad Natl Med; 2006 Nov; 190(8):1745-59. PubMed ID: 17650757
[TBL] [Abstract][Full Text] [Related]
58. [Results of the neonatal screening on Western Andalusia after a decade of experience.].
Delgado-Pecellín C; Álvarez Ríos I; Bueno Delgado MDA; Jiménez Jambrina MM; Quintana Gallego ME; Ruiz Salas P; Marcos Luque I; Melguizo Madrid E
Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33323920
[TBL] [Abstract][Full Text] [Related]
59. [Sickle cell disease in heel injection screening. I].
Peters M; Appel IM; Cnossen MH; Breuning-Boers JM; Heijboer H
Ned Tijdschr Geneeskd; 2009 May; 153(18):854-7. PubMed ID: 19475863
[No Abstract] [Full Text] [Related]
60. Haemoglobinopathies and newborn haemoglobinopathy screening in Germany.
Dickerhoff R; Genzel-Boroviczeny O; Kohne E
J Clin Pathol; 2009 Jan; 62(1):34. PubMed ID: 19103856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
